Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Datasea Reports Record Fiscal Year 2025 Revenue of $71.62 Million, Up 199% Year-over-Year 2025-09-26 21:30
Concord Medical Reports Financial Results for the First Half of 2025 2025-09-26 19:30
Jacobio Chairman and Concerted Parties Increase Shareholding by Nearly HK$100 Million, Demonstrating Confidence in Long-term Growth 2025-09-26 08:47
Bambusa Therapeutics Announces Highly Positive Healthy Volunteer Results and First Atopic Dermatitis Patient Dosed in Phase I Trial of BBT001 2025-09-25 22:04
The FDA Granted Orphan Drug Designation to Biostar Pharma's Utidelone for the Treatment of Pancreatic Cancer 2025-09-25 21:37
Flat Medical Establishes Clinical Advisory Board for Pain Interventions, Names Dr. Krishnan Chakravarthy as Chairman 2025-09-25 21:00
WuXi Biologics Launches WuXia™4.0, Targeted Integration Cell Line Platform TrueSite TI™,to Accelerate Biologics Development with High Titer and Superior Stability 2025-09-25 19:42
Lunit, CellCarta Announce Global Alliance to Expand Access to Digital Pathology AI for Clinical Trials 2025-09-24 21:00
GCCL and Frontage Laboratories Announce Strategic Collaboration to Strengthen Global Clinical Trial Capabilities 2025-09-24 13:29
Noul Secures FDA Registration for Cervical Cancer Diagnostic Cartridge 2025-09-23 21:00
HKeyBio Lauched the Most Comprehesive Non-human Primate Autoimmune & Allergic Disease Model Matrix to Redefining Clinical Translation 2025-09-23 20:35
Mindray Unveils Project 2030 and Re-writes the Future of Women's Health Ultrasound at ISUOG 2025-09-23 13:48
GC Biopharma Submits IND Application for Phase 1 Clinical Trial of COVID-19 mRNA Vaccine in Korea 2025-09-23 09:41
Galux Demonstrates De Novo Antibody Design With Structural and Functional Validation Across Eight Targets 2025-09-22 21:00
Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine 2025-09-22 21:00
LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting 2025-09-22 20:00
Akeso Announces First Patient Dosed in Registrational Phase II Study of TIGIT/TGF-β Bifunctional Antibody Fusion Protein AK130 Combined with Ivonescimab for Advanced Pancreatic Cancer 2025-09-22 14:51
Ascletis Announces ASC47 in Combination with Semaglutide Demonstrated Up to 56.2% Greater Relative Reduction in Body Weight in Participants with Obesity Compared to Semaglutide Monotherapy 2025-09-22 08:10
WuXi AppTec Implements Its First Interim Dividend Plan, Distributing RMB1.03 Billion in Cash Dividends 2025-09-22 08:00
Innovent Announces Mazdutide Received Approval from China's NMPA for Glycemic Control in Adults with Type 2 Diabetes 2025-09-19 18:01